论文部分内容阅读
紫竹药业向北京、天津多家“非典”一线医院提供临床对症治疗用药复方樟柳碱注射液
Zizhu Pharmaceutical to Beijing, Tianjin, a number of “SARS” first-line hospital clinical symptomatic treatment of Compound anisodine injection